ObsEva Files half Year 2023 Financial Statements
27 Septembre 2023 - 7:00AM
ObsEva Files
half Year 2023
Financial Statements
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss
Exchange
Geneva,
Switzerland –
September 27,
2023 – ObsEva SA (SIX:
OBSN), a biopharmaceutical company developing and commercializing
novel therapies to improve women’s reproductive health, today
published its Half Year 2023 Financial Statements. The Half Year
2023 Financial Statements may be found on the financial section of
the Company’s website, here or directly via the link here.
About ObsEva
ObsEva is a biopharmaceutical company developing
novel therapies to improve women’s reproductive health and
pregnancy. ObsEva has established a development program focused on
improving in vitro fertilization success rates. ObsEva is listed on
the SIX Swiss Exchange where it is traded under the ticker symbol
“OBSN”. For more information, please visit www.ObsEva.com.
For further information, please
contact:
For general information:
contact@obseva.ch
For investors information:
IR@obseva.ch
###
- ObsEva_Half Year 2023 Earnings Release_Pdf
ObsEva (NASDAQ:OBSV)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
ObsEva (NASDAQ:OBSV)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025
